HSRProj will be retired on September 14, 2021, no updates will be made to HSRProj after this date.
Detailed information about this transition can be found on the June 3, 2021 Technical Bulletin post.
If you have questions or suggestions, please contact NLM Customer Service.
Information about ongoing health services research and public health projects
|Comparative risks and benefits of gender reassignment therapies|
|Investigator (PI):||Goodman, Michael|
|Performing Organization (PO):||
(Current): Emory University, Rollins School of Public Health, Department of Epidemiology / (404) 727-8710
|Supporting Agency (SA):||Patient-Centered Outcomes Research Institute (PCORI)|
|Record Source/Award ID:||PCORI/AD-12-11-4532|
|Funding:||Total Award Amount: $2,103,856|
|Award Information:||PCORI: More information and project results (when completed)|
|Abstract:||The goal of this study is to understand the short- and long-term health issues among transgender persons who had or are planning to have a sex change treatment. Members of the transgender community and their doctors express concerns about mental and physical health problems in this group of people; however, large studies of transgender persons in the United States have not been conducted. This project is an electronic medical record-based study evaluating a group of 6,500 transgender individuals, whose care is covered by the Veterans Administration (nationally) or by Kaiser Permanente (in Georgia and in northern and southern California). In this study, we will compare frequencies of various diseases and deaths from various causes in transgender persons and separately in those who request female-to-male and male-to-female sex change to similar measures in a sample of men and women who are not transgender and are of the same age and race. We will also compare health problems by treatment categories (e.g., no medical treatment, versus treatment with hormones only, versus hormones plus surgery). The proposed project will be carried out by a team that includes experts in chronic and infectious diseases, mental disorders, and sexual minority health issues. All of the project activities will be implemented in consultation with the study advisors who will serve as advocates for the transgender community. This will likely be the largest study of transgender persons available to date, and the first study of its kind conducted in the United States. More on this project: Lauren E. Holz and Michael Goodman, Epidemiology of Advanced Prostate Cancer: Overview of Known and Less Explored Disparities in Prostate Cancer Prognosis. Current Problems in Cancer. 2015 Jan-Feb;39(1):11-6. doi: 10.1016/j.currproblcancer.2014.11.003.|
|Record History:||('2017: Project extended to 2017.',) ('2018: Project extended to 2018.',)|